Dosimetric feasibility of ablative dose escalated focal monotherapy with MRI-guided high-dose-rate (HDR) brachytherapy for prostate cancer.

CONCLUSION: Focal ablative dose-escalated radiation is feasible with the proposed protocol. Prospective studies are warranted to determine the clinical outcomes. PMID: 27916416 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/27916416?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 30, 2016 Category: Radiology Authors: Hosni A, Carlone M, Rink A, Ménard C, Chung P, Berlin A Tags: Radiother Oncol Source Type: research